Journal article
CASE REPORTS : FOLLICULOTROPIC MYCOSIS FUNGOIDES RESPONDING TO BEXAROTENE GEL
Journal of drugs in dermatology, Vol.7(2), pp.169-171
2008
Abstract
Folliculotropic mycosis fungoides (FMF) is an uncommon and potentially aggressive form of cutaneous T cell lymphoma (CTCL). Phototherapy, radiotherapy, and systemic chemotherapy are the most commonly employed treatment options, but may have limited success and common adverse reactions. Bexarotene gel is a topical retinoid X receptor (RXR) agonist with activity on the follicular unit that has not been previously reported in the management of FMF. The case of a 73-year-old male with FMF that responded to bexarotene gel is presented.
Details
- Title: Subtitle
- CASE REPORTS : FOLLICULOTROPIC MYCOSIS FUNGOIDES RESPONDING TO BEXAROTENE GEL
- Creators
- Hobart W Walling - Town Square Dermatology, Coralville, IA, United StatesBrian L Swick - University of IowaPedram Gerami - Northwestern UniversityRichard K Scupham - Iowa Pathology Associates, Des Moines, IA, United States
- Resource Type
- Journal article
- Publication Details
- Journal of drugs in dermatology, Vol.7(2), pp.169-171
- Publisher
- Physicians Continuing Education Corp
- ISSN
- 1545-9616
- Language
- English
- Date published
- 2008
- Academic Unit
- Pathology; Dermatology
- Record Identifier
- 9984296194502771
Metrics
6 Record Views